Transaction in Own Shares

Summary by AI BETAClose X

Smith & Nephew plc has purchased 1,417,110 ordinary shares between July 31, 2026, and August 6, 2026, as part of its $250 million share buyback program. These purchases, executed by Merrill Lynch International, involved an aggregate cost of £15,717,098.05, with an average price of £11.0852 per share. Since May 8, 2026, the company has repurchased a total of 15,676,907 shares for $236,542,051.81. Following these transactions, Smith & Nephew holds 39,293,137 shares in treasury, leaving 838,440,613 ordinary shares outstanding.

Disclaimer*

Smith & Nephew Plc
07 August 2026
 

7 August 2026

Smith & Nephew plc
Transactions in own shares

 

Smith & Nephew plc (the "Company") announces that from 31 July 2026 up to and including 6 August 2026 it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $250 million share buyback programme announced on 6 May 2026 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 6 May 2026.

 

Date of purchase

Aggregate number of ordinary shares purchased

Lowest price paid per ordinary share

Highest price paid per ordinary share

Average price paid per ordinary share

31 Jul 2026

114,774

1,156.00p

1,178.50p

1,164.66p

3 Aug 2026

113,112

1,180.00p

1,216.00p

1,200.65p

4 Aug 2026

148,486

1,102.50p

1,149.00p

1,124.38p

5 Aug 2026

493,245

1,097.00p

1,137.50p

1,108.81p

6 Aug 2026

547,493

1,089.50p

1,112.50p

1,097.65p

 

The Company intends to hold these shares in Treasury and then either cancel them or retain them for the purpose of satisfying awards under the Company's employee share plans.

 

Since 8 May 2026, the Company has purchased 15,676,907 shares at a cost of $236,542,051.81.

 

Following the purchases of these shares, the Company holds 39,293,137 of its ordinary shares in treasury. The Company's issued share capital, with one voting right per share consists of 838,440,613 ordinary shares of US20¢ each (excluding treasury shares). The figure of 838,440,613 should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of UKLR 9.6.6R.

The table below contains detailed information about the purchases made as part of the buyback programme.

 

Schedule of Purchases

 

Shares purchased:          1,417,110 (ISIN: GB0009223206)

 

Dates of purchases:        31 July 2026 to 6 August 2026

 

Investment firm:               Merrill Lynch International

 

Aggregate information:

 

Venue

Volume weighted average price paid per ordinary share (GBP)

Number of ordinary shares repurchased

Lowest price per ordinary share (GBP)

Highest price per ordinary share (GBP)

London Stock Exchange

11.1852

1,370,434

10.8950

12.1600

CBOE Europe BXE

-

-

-

-

CBOE Europe CXE

11.0210

46,676

10.9150

11.1050

Turquoise

-

-

-

-

Aquis Stock Exchange

-

-

-

-

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a schedule of individual trades by Merrill Lynch International is available below:

 

Individual Transactions:

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7780P_1-2026-8-7.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings